| Overview |
| bsm-90236r-50µL |
| GCLM Recombinant Antbody Kit (KD-Validated) |
| WB, FCM, IC |
| Knockdown Validated |
| Human, Mouse, Rat |
| Specifications |
| Unconjugated |
| Rabbit |
| A synthesized peptide derived from human GCLM |
| 65-100/274 |
| Recombinant |
| IgG |
| Lot dependent |
| Affinity Purified |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| -20 °C |
| Target |
| 2730 |
| P48507 |
| GCLM; Glutamate-Cysteine Ligase Modifier Subunit; GLCLR; Gamma-Glutamylcysteine Synthetase Regulatory Subunit; Glutamate--Cysteine Ligase Regulatory Subunit; Gamma-ECS Regulatory Subunit; GCS Light Chain; Glutamate-Cysteine Ligase (Gamma-Glutamylcysteine Synthetase) Regulatory (30.8kD); Glutamate-Cysteine Ligase Modifier Subunit Delta2 Alternative Splicing; Glutamate-Cysteine Ligase Regulatory Protein; Glutamate-Cysteine Ligase Modifier Subunit; Glutamate--Cysteine Ligase Modifier Subunit; Gamma-Glutamylcysteine Synthetase; GSC Light Chain |
| Cell Line: Hela Knockdown technology: shRNA Knockdown |
| Application Dilution |
| WB |
1:300-5000 |
| FCM |
1:20-100 |
| IC |
1:1000 |